Form 8-K - Current report:
SEC Accession No. 0001062822-24-000051
Filing Date
2024-09-16
Accepted
2024-09-16 06:51:46
Documents
15
Period of Report
2024-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20240913.htm   iXBRL 8-K 27662
2 EX-10.1 exh101wadeseparationagreem.htm EX-10.1 20455
3 EX-10.2 exh102wadeconsultingagreem.htm EX-10.2 41784
  Complete submission text file 0001062822-24-000051.txt   228494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20240913.xsd EX-101.SCH 1895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20240913_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20240913_pre.xml EX-101.PRE 12504
17 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20240913_htm.xml XML 2738
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 241299292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)